Visceral leishmaniasis in a renal transplant recipient: diagnostic and therapeutic problems.
Visceral leishmaniasis is infrequently reported in renal transplant recipients. A 40-year-old renal transplant recipient developed hepatosplenomegaly and pyrexia of unknown origin 5 months after transplantation. Visceral leishmaniasis was confirmed on bone marrow examination. The usual dose of antiparasitic therapy with stibogluconate sodium failed to eradicate Leishmania donovani. High-dose conventional therapy with stibogluconate sodium for an extended period of time was successful in the treatment of a relapse of leishmaniasis.
Sharma
R K
RK
Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Jha
R
R
Kumar
P
P
Kher
V
V
Gupta
A
A
Kumar
A
A
Gulati
S
S
Arora
P
P
Murari
M
M
Bhandari
M
M
D000328:Adult; D000967:Antimony Sodium Gluconate / Q000008:administration & dosage; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D007898:Leishmaniasis, Visceral / Q000175:diagnosis* / Q000188:drug therapy
D000981:Antiprotozoal Agents; D000967:Antimony Sodium Gluconate